Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20682854 | 1.00 | HTR2C (0.36) | HTR2CSLC6A4 | |
| SCHEMBL2022302 | 0.89 | — | — | |
| SCHEMBL19407196 | 0.89 | — | — | |
| SCHEMBL19715628 | 0.89 | — | — | |
| SCHEMBL2212908 | 0.89 | — | — | |
| SCHEMBL15782488 | 0.78 | HTR2C (0.35) | HTR2CSLC6A4 | |
| SCHEMBL14325292 | 0.76 | HTR2C (0.34) | HTR2CSLC6A4 | |
| SCHEMBL10110551 | 0.76 | TP53 (0.30) | — | |
| SCHEMBL10831129 | 0.72 | — | — | |
| SCHEMBL22811147 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023235380-A1 | MACROLIDES FOR TREATING GENETIC DISEASES | ZIKANI THERAPEUTICS, INC. (US) | 2023-12-07 | — | — | WO | disclosed |
| WO-2021222673-A1 | PROCESSES FOR THE PREPARATION OF A KINASE INHIBITOR | EXELIXIS, INC. (US) | 2021-11-04 | — | — | WO | disclosed |
| EP-3134084-B1 | METHOD OF TREATING LUNG ADENOCARCINOMA | EXELIXIS INC (US) | 2021-03-17 | — | — | EP | disclosed |
| EP-2768796-B1 | PROCESS FOR PREPARING QUINOLINE DERIVATIVES | EXELIXIS INC (US) | 2019-11-20 | — | — | EP | disclosed |
| EP-2621481-B1 | DUAL INHIBITORS OF MET AND VEGF FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER AND OSTEOBLASTIC BONE METASTASES | EXELIXIS INC (US) | 2019-08-14 | — | — | EP | disclosed |
| WO-2019148044-A1 | COMPOUNDS FOR THE TREATMENT OF KINASE-DEPENDENT DISORDERS | EXELIXIS, INC. (US) | 2019-08-01 | — | — | WO | disclosed |
| EP-2727919-B1 | BENZOCYCLOHEPTANETHIOPHENE DERIVATIVES FOR ANTI-ALLERGIC REACTIONS | FUJIAN MINDONG REJUVENATION PHARMACEUTICAL CO LTD (CN) | 2019-05-08 | — | — | EP | disclosed |
| EP-2616442-B1 | INHIBITORS OF PI3K-DELTA AND METHODS OF THEIR USE AND MANUFACTURE | EXELIXIS INC (US) | 2018-08-08 | — | — | EP | disclosed |
| EP-2909188-B1 | NOVEL PROCESS FOR MAKING COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | EXELIXIS INC (US) | 2018-03-07 | — | — | EP | disclosed |
| EP-2758057-B1 | METHOD FOR TREATING OSTEOPOROSIS | EXELIXIS INC (US) | 2017-05-31 | — | — | EP | disclosed |